Home › Compare › CGRA vs JNJ

CGRA vs JNJ: Dividend Comparison 2026

CGRA yields 100000.00% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CGRA wins by $4.832206901976048e+26M in total portfolio value
10 years
CGRA
CGRA
● Live price
100000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.832206901976048e+26M
Annual income
$482,271,988,201,431,700,000,000,000,000,000.00
Full CGRA calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CGRA vs JNJ

📍 CGRA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCGRAJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CGRA + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CGRA pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CGRA
Annual income on $10K today (after 15% tax)
$8,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$409,931,189,971,216,900,000,000,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, CGRA beats the other by $409,931,189,971,216,900,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CGRA + JNJ for your $10,000?

CGRA: 50%JNJ: 50%
100% JNJ50/50100% CGRA
Portfolio after 10yr
$2.416103450988024e+26M
Annual income
$241,135,994,100,715,840,000,000,000,000,000.00/yr
Blended yield
99.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CGRA
No analyst data
Altman Z
-9.4
Piotroski
2/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CGRA buys
0
JNJ buys
0
No recent congressional trades found for CGRA or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCGRAJNJ
Forward yield100000.00% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$4.832206901976048e+26M$20.0K ✓
Annual income after 10y$482,271,988,201,431,700,000,000,000,000,000.00 ✓$827.78
Total dividends collected$4.8315851896727036e+26M$5.6K ✓
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CGRA vs JNJ ($10,000, DRIP)

YearCGRA PortfolioCGRA Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,010,700$10,000,000.00$10,676$355.77+$10.00M → CGRA
2$9,366,505,842$9,355,794,392.52$11,407$389.39+$9366.49M → CGRA
3$8,191,091,111,834$8,181,068,950,583.78$12,198$426.53+$8191091.10M → CGRA
4$6,695,134,751,499,451$6,686,370,284,009,789.00$13,056$467.62+$6695134751.49M → CGRA
5$5,114,850,040,116,031,000$5,107,686,245,931,928,000.00$13,987$513.12+$5114850040116.02M → CGRA
6$3,652,290,278,277,141,000,000$3,646,817,388,734,216,400,000.00$14,998$563.56+$3652290278277141.00M → CGRA
7$2,437,583,176,648,375,000,000,000$2,433,675,226,050,619,000,000,000.00$16,098$619.52+$2437583176648375296.00M → CGRA
8$1,520,612,508,079,010,700,000,000,000$1,518,004,294,079,997,000,000,000,000.00$17,295$681.69+$1.5206125080790106e+21M → CGRA
9$886,637,379,601,106,600,000,000,000,000$885,010,324,217,461,900,000,000,000,000.00$18,599$750.82+$8.866373796011065e+23M → CGRA
10$483,220,690,197,604,800,000,000,000,000,000$482,271,988,201,431,700,000,000,000,000,000.00$20,022$827.78+$4.832206901976048e+26M → CGRA

CGRA vs JNJ: Complete Analysis 2026

CGRA — Stock

CGrowth Capital, Inc. operates as a holding company for businesses and assets focusing on mining, minerals, and exploration activities in the United States. The company provides capital, processing applications, and various services for land owners specific to the oil and gas exploration, as well as mining and metal processing. It also provides a range of services and solutions that are designed to assist land owners with monetizing undervalued assets by bringing commodities, such as gold and silver to market, as well as purchases secondary claims and assets in various locations for providing ore processing, drilling, and exploration support. The company was formerly known as Anchor Pacific Underwriters Inc. and changed its name to CGrowth Capital, Inc. in February 2010. CGrowth Capital, Inc. was founded in 1986 and is based in Silverdale, Washington.

Full CGRA Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CGRA vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CGRA vs SCHDCGRA vs JEPICGRA vs OCGRA vs KOCGRA vs MAINCGRA vs ABBVCGRA vs MRKCGRA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.